Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 25, 2015 6:02 AM ET

Healthcare Providers and Services

Company Overview of Advanced Care Scripts, Inc.

Company Overview

Advanced Care Scripts, Inc. provides specialty pharmacy management services for patients on biotech therapies. The company engages in the management and dispensing of specialty medications and oral oncology products, as well as provides medicare reimbursement support services. It also offers specialty pharmacy adherence and clinical management programs, as well as compliance management, patient education, proactive side effect management, and other clinical intervention services to support patients receiving specialty medications. The company was founded in 2004 and is based in Orlando, Florida. As of July 16, 2008, Advanced Care Scripts, Inc. operates as a subsidiary of Omnicare Inc.

6251 Chancellor Drive

Suite 101

Orlando, FL 32809

United States

Founded in 2004

Phone:

407-812-9441

Fax:

866-679-7131

Key Executives for Advanced Care Scripts, Inc.

President
Compensation as of Fiscal Year 2014.

Advanced Care Scripts, Inc. Key Developments

Pfizer Selects Advanced Care Scripts to Provide Specialty Pharmacy Services for Ibrance

Pfizer has selected Advanced Care Scripts, or ACS, a specialty pharmacy platform of Omnicare Specialty Care Group, or SCG, as a specialty pharmacy authorized to dispense Pfizer's Ibrance. Ibrance was recently approved by the FDA and is intended for postmenopausal women with estrogen receptor (ER) -positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer as initial endocrine-based therapy for their metastatic disease. It is to be used in combination with letrozole, another FDA-approved product used to treat certain kinds of breast cancer in postmenopausal women. The FDA granted Ibrance breakthrough therapy designation and priority review due to the preliminary clinical evidence that the drug may offer a substantial improvement over available therapies.

Similar Private Companies By Industry

Company Name Region
Lakeside Care, Inc. United States
iLinkMD Corporation United States
Senior Health Solutions, LLC United States
Vantus, Inc. United States
DaVita-Riverside, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Advanced Care Scripts, Inc., please visit www.omnicarescg.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.